The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly

Keskin F. E. , Ozkaya H. M. , Ferahman S. , Haliloglu O., Karatas A., Aksoy F., ...More

Experimental and Clinical Endocrinology and Diabetes, vol.127, no.7, pp.437-444, 2019 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 127 Issue: 7
  • Publication Date: 2019
  • Doi Number: 10.1055/a-0629-9223
  • Title of Journal : Experimental and Clinical Endocrinology and Diabetes
  • Page Numbers: pp.437-444


Purpose Prevalence of papillary thyroid cancer (PTC) is increased in patients with acromegaly. We aimed to determine the protein expression of BRAF, RAS, RET, insulin like growth factor 1(IGF1), Galectine 3, CD56 in patients with PTC related acromegaly and to compare the extensity of these expressions with normal PTC patients and benign thyroid nodules.